Markets › United States › NAS › FENC

Fennec Pharmaceuticals Inc

NAS:FENCHealthcareCBOEFTSE:MRUTnasdaq_composite

$10.06−2.57%LiveIn session · ≈ AED 36.93 · Market cap $352.6M · Next earnings Thu 5 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	100.0%	—	94.4%	94.1%	93.3%	91.6%	—	—
Operating margin	−10,520.6%	—	−1,481.3%	−61.4%	5.2%	−14.2%	−14.2%	+0.0 pts
Net margin	−10,652.4%	—	−1,544.9%	−75.5%	−0.9%	−21.8%	−21.8%	+0.0 pts
EBITDA margin	−10,647.1%	—	−1,471.5%	−58.2%	10.1%	−16.7%	—	—
Return on equity	−62.3%	−110.0%	923.1%	138.1%	7.4%	−27.8%	−27.8%	+0.0 pts
Return on assets	−57.6%	−77.4%	−88.0%	−59.7%	−1.0%	−13.9%	−13.9%	+0.0 pts
Return on capital employed	−61.5%	−83.0%	−101.8%	−67.6%	6.5%	−10.7%	—	—
Debt / equity	0.0×	0.3×	−9.7×	−2.7×	−3.3×	0.0×	0.0×	—
Debt / assets	0.0%	22.3%	92.4%	115.2%	43.0%	0.0%	—	—
Interest coverage	0.0×	−136.7×	−23.2×	−3.8×	0.6×	−3.1×	—	—
Current ratio	13.4×	13.5×	5.8×	3.6×	6.4×	6.3×	6.3×	+0.0%
Quick ratio	13.4×	13.5×	5.7×	3.3×	6.2×	6.2×	—	—
Cash ratio	12.9×	12.8×	5.2×	1.8×	3.8×	3.5×	3.5×	+0.0%
Asset turnover	0.0×	0.0×	0.1×	0.8×	1.1×	0.6×	—	—
Inventory turnover	—	—	0.1×	0.6×	3.0×	2.4×	—	—
Receivables turnover	—	—	1.0×	2.4×	3.7×	1.9×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—